Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-17

FDA Approved: SEZABY — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved SEZABY (phenobarbital sodium) from Sun Pharmaceutical Industries via an original NDA. It is an anticonvulsant indicated for seizure disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEZABY (Phenobarbital sodium)

Snippet

ORIG AP for SEZABY (PHENOBARBITAL SODIUM)